Congressional investigators are expanding their inquiry of Emergent BioSolutions to encompass the firm’s relationship with the two companies that hired it to produce their Covid shots.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register. By continuing to use this site, you are consenting to our use of cookies.